New Florida rules advise against drugs for depression, anxiety for kids
The Florida Department of Health recently released new guidelines advising against the use of psychotropic medications for children between the ages of 5 and 17. The guidance suggests that drugs used to treat mental health conditions like depression, anxiety, or attention-deficit disorders should be avoided in most instances. Instead, the state recommends that providers look toward alternative strategies such as individual psychotherapy and evidence-based behavior management.
State Surgeon General Dr. Joseph A. Ladapo stated that treatment should focus on a clear understanding of a child's specific needs and circumstances. The department emphasizes that while these medications have a role when medically necessary, they should not serve as a replacement for psychosocial care or therapy. This move aligns with a broader push to re-evaluate how pediatric mental health care is administered across the state.
This policy update reflects ongoing conversations regarding the frequency of psychiatric drug prescriptions for minors. The guidance encourages clinicians to perform thorough assessments and consider all potential risks before pursuing pharmaceutical interventions. Officials state that the goal of this document is to ensure parents have sufficient information to make informed decisions for their children.
Critics, including representatives from the American Academy of Child and Adolescent Psychiatry, have expressed concerns that these guidelines might challenge established medical standards. They argue that decisions regarding mental health services must remain rooted in evidence and clinical expertise. The Florida Department of Health maintains that the new rules are intended to raise awareness and ensure children receive the most appropriate care.

